Top Markets
Coin of the day
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals, Inc.

SNNAQ
Rankning i aktier #42234
Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm... Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm dedicated to discovering and advancing pharmaceutical treatments across diverse therapeutic fields. Its primary focus involved crafting therapies within immunology and inflammation, specifically targeting particular tissue pathways, notably in the skin. Among its pipeline, SNA-120 stood out as a pioneering, first-in-class inhibitor of tropomyosin receptor kinase A, undergoing Phase IIb clinical evaluation for addressing psoriasis and its associated itching. Another key candidate, SNA-125, a topical dual Janus kinase 3 inhibitor, progressed through Phase I/II clinical studies for conditions like atopic dermatitis, psoriasis, and pruritus. Furthermore, Sienna was advancing SNA-001, a topical suspension incorporating silver particles, into pivotal clinical trials not only for acne treatment but also for diminishing light-colored hair, encompassing shades such as white, gray, blonde, light brown, and light red. Established in 2010 and based in Westlake Village, California, the company originally operated as Sienna Labs, Inc. before rebranding as Sienna Biopharmaceuticals, Inc. in February 2016. However, the firm faced significant financial challenges, initiating Chapter 11 bankruptcy proceedings on September 16, 2019, which subsequently converted to Chapter 7 liquidation on December 18, 2019.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$3.09K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Sienna Biopharmaceuticals, Inc. (SNNAQ)

Kategori

Pris SNNAQ med marknadsvärde på B
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.0001
Marknadsvärde för Sienna Biopharmaceuticals, Inc.(SNNAQ)
Marknadsvärde: $3.09K
Från och med August 2026 har Sienna Biopharmaceuticals, Inc. ett börsvärde på $3.09K. Detta gör Sienna Biopharmaceuticals, Inc. till det 42234th mest värdefulla företaget i världen enligt våra data. Börsvärdet, även kallat market cap, är det totala marknadsvärdet av ett börsnoterat företags utestående aktier och används ofta för att uppskatta ett företags värde.
Marknadsvärdehistorik för Sienna Biopharmaceuticals, Inc. från 2017 till 2026
SNNAQ jämfört med topp 5 mest populära stocks
Pris för SNNAQ Tillgång B Marknadsvärdet för B Resultat
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$174,162 $3.09K
$5.383T +174,162,389,417.96%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$143,106 $3.09K
$4.423T +143,105,506,329.57%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$134,596 $3.09K
$4.160T +134,596,227,628.31%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$118,516 $3.09K
$3.663T +118,515,717,693.59%
Sienna Biopharmaceuticals, Inc. Sienna Biopharmaceuticals, Inc.
$93,537.00 $3.09K
$2.891T +93,537,003,956.94%